Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Screening Strategy for Bladder Cancer in at Risk Patients

NCT05646485 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT05646485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05646485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Screening Strategy for Bladder Cancer in at Risk Patients
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 5, 2023
Completion date
April 30, 2028
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, hematuria, smoking cessation, urothelial carcinoma